申请人:AstraZeneca AB
公开号:EP2383268A1
公开(公告)日:2011-11-02
This invention relates to novel compounds having the formula (I):
and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
本发明涉及具有式 (I) 的新型化合物:
及其药物组合物和使用方法。这些新型化合物可用于治疗癌症。